When risks outweigh benefits: A review of the guideline on benzodiazepine tapering.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 42225377.
- Also identified by DOI 10.3949/ccjm.93a.25102.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
About 1 in 10 adults in the United States report having used benzodiazepines in the past year. These medications carry substantial risks, including falls, cognitive impairment, overdose, and death, particularly when combined with alcohol or opioids. The American Society of Addiction Medicine, in collaboration with 9 other professional societies, has issued recommendations on when and how to taper and discontinue benzodiazepines. The authors of this article summarize important points from the guideline, aimed at all who provide long-term benzodiazepine prescriptions.
Medical subject headings
- Benzodiazepines
- Practice Guidelines as Topic
- Drug Tapering